• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

Recent Advances in the Study of 1-(1-methyl-1H-indol-4-yl)-Ethanone (CAS: 120160-29-4) in Chemical Biology and Pharmaceutical Research

The compound 1-(1-methyl-1H-indol-4-yl)-Ethanone (CAS: 120160-29-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and potential as a lead molecule in drug discovery.

Recent studies have highlighted the role of 1-(1-methyl-1H-indol-4-yl)-Ethanone as a key intermediate in the synthesis of more complex indole derivatives, which are widely recognized for their pharmacological properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits promising inhibitory activity against specific kinase targets implicated in cancer progression. The study utilized in vitro assays and molecular docking simulations to elucidate the binding mechanisms, revealing a high affinity for the ATP-binding sites of these kinases.

Further investigations into the pharmacokinetic properties of 1-(1-methyl-1H-indol-4-yl)-Ethanone have been conducted to assess its viability as a drug candidate. A preclinical study reported in Bioorganic & Medicinal Chemistry Letters (2024) explored its metabolic stability and bioavailability, indicating moderate hepatic clearance and reasonable oral absorption in rodent models. These findings suggest that structural modifications may be necessary to optimize its drug-like properties for clinical development.

In addition to its potential in oncology, recent research has explored the anti-inflammatory and neuroprotective effects of 1-(1-methyl-1H-indol-4-yl)-Ethanone. A 2024 paper in ACS Chemical Neuroscience demonstrated that this compound could modulate microglial activation and reduce neuroinflammation in cellular models of neurodegenerative diseases. The study proposed that the indole scaffold's ability to interact with inflammatory signaling pathways makes it a promising candidate for further investigation in CNS disorders.

The synthetic accessibility of 1-(1-methyl-1H-indol-4-yl)-Ethanone has also been a focus of recent work. A novel, scalable synthesis route was reported in Organic Process Research & Development (2023), featuring improved yield and purity compared to traditional methods. This advancement is particularly significant for potential industrial-scale production, addressing one of the key challenges in translating this compound from bench to bedside.

Looking forward, several research groups have initiated structure-activity relationship (SAR) studies to explore derivatives of 1-(1-methyl-1H-indol-4-yl)-Ethanone. Preliminary results presented at the 2024 American Chemical Society national meeting showed that modifications at the ketone position could significantly enhance both potency and selectivity against various biological targets. These findings open new avenues for the rational design of next-generation therapeutics based on this chemical scaffold.

In conclusion, the growing body of research on 1-(1-methyl-1H-indol-4-yl)-Ethanone (CAS: 120160-29-4) underscores its potential as a versatile building block in medicinal chemistry and a promising starting point for drug discovery. While challenges remain in optimizing its pharmacological profile, the recent advances in understanding its biological activities and improving synthetic methodologies position this compound as an important focus for future research in chemical biology and pharmaceutical development.

• 61640-20-8(1-(1-methyl-1H-indol-5-yl)ethan-1-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)